Blacks Experience Hip Osteoarthritis as Frequently as Whites

Article

Dr. Joanne Jordan, director, Thurston Arthritis Research Center at UNC, has found that blacks are not protected from osteoarthritis of the hip as once thought.

In this online video from the Doctor's Channel, Dr. Joanne Jordan, director of the University of North Carolina Thurston Arthritis Research Center, discusses a study in which she and colleagues have found that African Americans are not protected from osteoarthritis of the hip as once thought.

Click here to access ths third-party resource.

Related Videos
Connective Tissue Disease Brings Dermatology & Rheumatology Together
What Makes JAK Inhibitors Safe in Dermatology
Potential JAK Inhibitor Combination Regimens in Dermatology
Therapies in Development for Hidradenitis Suppurativa
"Prednisone without Side Effects": The JAK Inhibitor Ceiling in Dermatology
Discussing Changes to Atopic Dermatitis Guidelines, with Robert Sidbury, MD, MPH
How Will Upadacitinib, Povorcitinib Benefit Hidradenitis Suppurativa?
The JAK Inhibitor Safety Conversation
Jonathan Silverberg, MD, PhD, MPH | Credit: George Washington University
Secukinumab and Bimekizumab for Hidradenitis Suppurativa
© 2024 MJH Life Sciences

All rights reserved.